In the present study, serum VEGF levels were higher in GC patients than healthy controls and high serum VEGF levels were correlated with poorly differentiated tumors, advanced clinical stages, locally advanced T stages, lymph node metastasis, and larger tumor sizes. The gene discussed is VEGFA; the disease is metastatic malignant neoplasm in the lymph nodes.